Save $$$ on Risperdal purchased online

Alkermes, Inc. (NASDAQ: ALKS) today announced financial results
for its third quarter of fiscal 2008. Financial highlights for the
quarter ended December 31, 2007 include:

— Sixth consecutive profitable quarter on a GAAP basis, with net
income of $168.9 million. Net income for the third quarter
included proceeds from the sale of the company’s stake in
Reliant Pharmaceuticals, Inc.

— Quarterly revenues of $50.8 million. World…

Gynecomastia (Male breast growth)
Male breast growth has significant emotional consequences for a pre-pubescent or adolescent boy. This condition is often an invitation for teasing from peers. Most boys faced with this tend to hide their chest when in public or to stay out of group activities altogether. Typically, boys suff…

Health care giant Johnson & Johnson in New Brunswick received separate subpoenas from three different U.S. attorney’s offices seeking information about its oversight of the marketing of three drugs sold by J&J subsidiaries. The products are Risperdal, a t…

The first generic versions of the antipsychotic drug Risperdal (risperidone) were approved Monday by the U.S. Food and Drug Administration.
The generic versions in several strengths will be manufactured by Teva Pharmaceuticals USA. They will have the same boxed warnings as the brand name drug, produced by Janssen Pharmaceuticals.

Related…

CAMBRIDGE, Mass. — Alkermes, Inc. (Nasdaq: ALKS) today announced that it has closed with institutional investors a private placement of 7% secured notes due 2018 with a face amount of $170 million. The transaction resulted in proceeds to Alkermes of approximately $145 million after allo…

The FDA has approved Risperdal Consta for treating schizophrenia. The product, marketed by Janssen Pharmaceutica …

Most Popular
10 Cheap Ways To Build Your Brand: Learn Why Branding Reinforcement Is Important For Your Business
Sample Marketing Resume
Winning the global challenge: The Japanese electronics companies’ race to innovate
Four Tips For Better Decision Making
Putting Busin…

The FDA last month approved Risperdal Consta (risperidone long-acting injection) for treating schizophrenia. It is the first long-acting, atypical antipsychotic the FDA has approved, reported Janssen Pharmaceutica, who is marketing the product.

Related Results

…

CAMBRIDGE, Mass. — Alkermes, Inc. (Nasdaq: ALKS) today announced that the Japanese organization of its partner Janssen-Cilag, Janssen Pharmaceutica K.K., submitted a new drug application to the Pharmaceuticals and Medical Devices Agency (PMDA) for marketing approval in Japan of RISPERDAL([R]) CONSTA([R]) [(risperidone) long-acting injection], an atypical antipsychotic medication for the treatment of schizophrenia. RISPERDAL CONSTA is the first and only long-acting, at…

TITUSVILLE, N.J., June 30 /PRNewswire-FirstCall/ — Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced that it has launched an authorized generic version of RISPERDAL(R) (risperidone) through Patriot Pharmaceuticals, L.L.C.
Patriot is a subsidiary of McNeil-PPC. …

LegalView.com would like to inform readers of its newly launched information portal dealing with the possibly unsafe prescription drugs Dostinex and Risperdal. Each of these information portals contains vital information for informing readers about the …